Tome Biosciences

Watertown, United States

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.

$213.0M raised

Dec 2023

Series A

Biotechnology Genetics Medical

Top Investors

Andreessen HorowitzARCH Venture PartnersPolaris PartnersLongwood FundBruker

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tome Biosciences

How much funding has Tome Biosciences raised?

Tome Biosciences has raised $213.0M in total funding. The most recent round was Series A. The last funding was announced in December 2023.

Who are Tome Biosciences's investors?

Tome Biosciences's investors include Andreessen Horowitz, ARCH Venture Partners, Polaris Partners, Longwood Fund, Bruker.

Where is Tome Biosciences headquartered?

Tome Biosciences is headquartered in Watertown, United States.

What does Tome Biosciences do?

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.

What stage is Tome Biosciences at?

Tome Biosciences is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 12, 2023.

MLA

"Tome Biosciences — Funding & Investors." VCBacked, December 12, 2023, https://www.vcbacked.co/company/tome-biosciences. Accessed June 4, 2026.

APA

VCBacked. (2023). Tome Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/tome-biosciences

Wikipedia (cite web)

{{cite web |title=Tome Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/tome-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 12, 2023.

Similar Companies in Biotechnology